Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...
CG Oncology, Inc.'s promising bladder cancer therapy has strong clinical results, competitive CR rates, and a $69 target ...
The overall number of monthly dividend decreases remains below the threshold consistent with recessionary conditions. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback